Week 11 - L3 - Bioinformatic Prediction and Experimental Validation of Post-Translational Modifications

Overview of Post-Translational Modification Databases

  • Online biological databases curate comprehensive information on post-translational modifications (PTMs) across thousands of proteins, compiled from years of experimental research.

  • These digital repositories enable the characterization of biochemical alterations that occur on a nascent polypeptide chain following protein synthesis.

  • Databases range from broad repositories cataloging holistic protein functional data to specialized platforms concentrating on specific chemical modifications, such as phosphorylation.

UniProt Database Architecture and Applications

  • Primary Repository Characteristics:

    • UniProt serves as one of the most foundational and comprehensive databases in protein science, cataloging thousands of individual proteins.

    • It synthesizes and summarizes all available empirical information regarding protein sequence, structure, and functional characteristics.

    • The resource has been in active development and continuously upgraded since approximately the year 20052005.

  • PTM Query Capabilities:

    • Users can search virtually any target protein to extract known literature and experimental data.

    • Specific database partitions provide detailed annotations on diverse post-translational modification sites identified across the protein sequence.

    • While UniProt provides a broad macro-level overview, specialized databases are required to interrogate distinct modification classes in high detail.

PhosphoSite Plus Features and Functional Analysis

  • Specialized Scope:

    • PhosphoSite Plus (also referenced as PhosphoCyte Plus) focuses specifically on protein phosphorylation and cataloging phosphoproteins across cellular systems.

    • The database houses an expanding registry approaching 600,000600,000 annotated post-translational modifications.

    • Access is open access, continuously curated, and interactive, delivering high-level systems biology annotations for experimentally verified PTMs.

  • Breadth of Modifications Cataloged:

    • While specialized for phosphorylation profiling, the resource annotates multiple other modification types, including:

    • Acetylation

    • Methylation

    • Ubiquitination

    • Glycosylation

  • Sequence Visualization Features:

    • Querying a protein of interest generates a linear sequence diagram.

    • The horizontal axis (xx-axis) plots individual residue numbers corresponding to specific amino acid positions along the polypeptide backbone.

    • Annotations situated above the sequence identify empirical sites of phosphorylation and other modifications.

  • Integration with Structural and Biological Metadata:

    • Structural topology (such as membrane orientation and transmembrane organization).

    • Biological function and molecular activity.

    • Regulatory significance and signaling roles of identified modification sites.

    • Biological context, cellular regulation, tissue-specific expressions, disease states, subcellular localizations, structural domains, and functional motifs.

Case Study: HER2 Topology and Phosphorylation Profiling

  • Clinical Relevance:

    • HER2 (Human Epidermal Growth Factor Receptor 2) is a well-established oncoprotein heavily implicated in the pathogenesis of breast cancer.

  • Structural Domain Organization:

    • Extracellular Domain: Extends into the extracellular environment.

    • Transmembrane Domain: Spans the lipid bilayer of the plasma membrane.

    • Cytosolic (Intracellular) Domain: Comprises the carboxyl terminus (CC-terminus) located inside the cytoplasm.

  • Modification Mapping:

    • PhosphoSite Plus sequence mapping demonstrates an extensive cluster of phosphorylation sites concentrated on the CC-terminus of HER2.

    • The spatial localization of these phosphorylation events on the intracellular cytosolic domain enables them to engage and modulate intracellular downstream signaling cascades.

Evolutionary Conservation and Disease Associations of Modification Sites

  • Evolutionary Cross-Species Conservation:

    • Query tabs within PhosphoSite Plus allow researchers to evaluate the evolutionary conservation of specific PTM residues across mammalian species and broader taxa.

    • High Conservation: Modification sites preserved across divergent phylogenetic lineages strongly suggest that the modification is essential for the protein to carry out its core physiological function.

    • Low Conservation: Modification sites restricted to specific lineages or individual organisms indicate organism-specific adaptations or specialized regulatory mechanisms.

  • Oncogenic and Pathological Linkages:

    • Database annotations connect specific residue modifications to cancer phenotypes.

    • Profiling tools assess how post-translational changes or sequence alterations at modification sites contribute to malignant transformation and tumor progression.

    • Identifies candidate regulatory sites to prioritize for detailed functional and mechanistic validation.

Deep Learning and Predictive Bioinformatics: MuCiteDape

  • Machine Learning Landscape:

    • Emerging bioinformatics tools utilize deep learning architectures to predict putative post-translational modification sites.

    • These predictive algorithms integrate multi-omic and structural datasets and represent a modern, rapidly growing domain within computational proteomics.

  • Predictive Pipeline using MuCiteDape:

    • Database Selection: MuCiteDape is a specialized predictive platform for post-translational modification mapping.

    • Parameter Input: Users specify the target modification type of interest (e.g., phosphorylation, glycosylation, or ubiquitination).

    • Query Submission: The primary amino acid sequence of the target protein is input into the platform.

    • Algorithmic Output: The model evaluates sequence contexts to predict probability scores for modifications occurring at discrete amino acid residues.

  • Limitations of Computational Prediction:

    • Outputs represent theoretical predictions rather than empirical biological facts.

    • Predicted modifications may not occur within native proteins inside living cells.

    • Unannotated, newly predicted sites strictly necessitate downstream benchtop experimental validation.

Experimental Validation Strategies for Predicted Modifications

  • Proteomic Characterization via Mass Spectrometry:

    • Proteomics and mass spectrometry serve as standard techniques to identify whether a physical mass shift corresponding to a predicted PTM exists on the endogenous or purified protein extracted from cellular models.

  • Site-Directed Mutagenesis:

    • Procedure: The target residue predicted to undergo modification is genetically mutated into an amino acid that cannot accept the chemical group (e.g., mutating a serine/threonine to an alanine to prevent phosphorylation).

    • Downstream Functional Assays:

    • Signal Transduction: Evaluating whether the non-modifiable mutant preserves signaling competence within designated signaling pathways.

    • Protein-Protein Interactions: Assessing whether loss of the modification disrupts or alters binding affinities with regulatory partners.

    • Phenotypic Impact: Monitoring whole-cell phenotypic changes induced by the loss of the functional post-translational modification site.